IP Library Granted Patent US 7,750,201
Granted Patent B2
US 7,750,201 · App. 11/783,667 · Granted Jul 6, 2010

Wound dressings with anti-microbial and chelating agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,750,201
App. No.
11/783,667
Granted
Jul 6, 2010
Kind
B2
Abstract

A wound dressing includes one or more layers containing a first anti-microbial agent and at least one of: a chelating agent, and a second anti-microbial agent.

Claims (38)

1. A wound dressing comprising one or more layers, each layer comprising a combination of fibers, the combination of fibers comprising at least a first fiber and a second fiber, wherein the first fiber is treated with at least a first anti-microbial agent comprising PHMB, and the second fiber is treated with at least a second anti-microbial agent.

2. The wound dressing of claim 1 , wherein the second fiber is compounded with at least one of: silver, zinc or copper.

3. The wound dressing of claim 2 , wherein the fiber is compounded with about, in percent by weight, 0.1% to about 40% silver.

4. The wound dressing of claim 2 , wherein the fiber comprises a core and a surrounding sheath, wherein the core is compounded with a first amount of silver, and the surrounding sheath is compounded with a second amount of silver, the second amount being greater than the first amount.

5. The wound dressing of claim 4 , wherein the first amount is less than about 20% by weight, and the second amount is less than about 70% by weight.

6. The wound dressing of claim 1 , wherein the combination of fibers comprises a homogenous blend of fibers.

7. The wound dressing of claim 1 , wherein the amount of first fiber present in the wound dressing is different than the amount of second fiber present in the wound dressing.

8. The wound dressing of clam 1 , wherein the density of either the first fiber, second fiber, or both, vary along a concentration gradient.

9. A wound dressing comprising a first layer, a second layer and a third layer, wherein at least one of the first, second and third layers contains an anti-microbial agent, and at least another of the first, second and third layers contains a chelating agent and wherein the anti-microbial agent and the chelating agent are separately contained in different layers of the wound dressing.

10. The wound dressing of claim 9 , wherein the first inner layer is substantially hydrophilic, and the second and third outer layers are substantially hydrophobic.

11. The wound dressing of claim 10 , wherein the second and third outer layers comprise a hydrophilic finish.

12. The wound dressing of claim 9 , further comprising a delivery agent for containing and releasing at least one of the anti-microbial agent and the chelating agent.

13. The wound dressing of claim 12 , wherein the delivery agent comprises one or more of: a hydrogel, phosphate glass, powdered starch, or a starch film.

14. The wound dressing of claim 9 , comprising:

a first inner layer containing the first anti-microbial agent; and

second and third outer layers adjacent to the first layer, the second and third layers containing the chelating agent.

15. The wound dressing of claim 9 , comprising:

a first inner layer containing the chelating agent; and

second and third outer layers adjacent to the first layer, the second and third layers containing the first anti-microbial agent.

16. The wound dressing of claim 9 , wherein the one or more layers are formed, at least in part, by one or more of: natural fibers, synthetic fibers, cellulose, cotton, Rayon, Nylon, acrylic, polyester, polyurethane, polyurethane foam, hydrogels, starch, a starch film, a biodegradable material, and combinations thereof.

17. The wound dressing of claim 9 , wherein the first anti-microbial agent comprises one or more of: PHMB, PHMB derivatives, PEHMB, silver, zinc, copper, and combinations thereof.

18. The wound dressing of claim 9 , wherein the chelating agent comprises EDTA.

19. The wound dressing of claim 9 , further comprising one or more of: a haemostatic agent, a protein inhibitor, a growth factor, collagen, an enzyme, an agent to induce directional bacterial growth, a means to impart bacteriacidal or bacteriostatic activity, an agent to destabilize metabolic activity, a vaso-dilator, an agent to inhibit or destroy biofilm formation, a light-activated agent, an ultrasound-activated agent, a sonication-activated agent, and combinations thereof.

20. The wound dressing of claim 9 , wherein the antimicrobial agent and the chelating agent are exclusively contained in different layers of the wound dressing.

21. A wound dressing, comprising:

a first inner layer; and

second and third outer layers, wherein each of the first, second and third layers contain an anti-microbial agent and a chelating agent.

22. The wound dressing of claim 21 , wherein the first inner layer is substantially hydrophilic, and the second and third outer layers are substantially hydrophobic.

23. The wound dressing of claim 22 , wherein the second and third outer layers comprise a hydrophilic finish.

24. The wound dressing of claim 21 , further comprising a delivery agent for containing and releasing at least one of the anti-microbial agent and the chelating agent.

25. The wound dressing of claim 24 , wherein the delivery agent comprises one or more of: a hydrogel, phosphate glass, powdered starch, or a starch film.

26. The wound dressing of claim 21 , wherein the one or more layers are formed, at least in part, by one or more of: natural fibers, synthetic fibers, cellulose, cotton, Rayon, Nylon, acrylic, polyester, polyurethane, polyurethane foam, hydrogels, starch, a starch film, a biodegradable material, and combinations thereof.

27. The wound dressing of claim 21 , wherein the first anti-microbial agent comprises one or more of: PHMB, PHMB derivatives, PEHMB, silver, zinc, copper, and combinations thereof.

28. The wound dressing of claim 21 , further comprising one or more of: a haemostatic agent, a protein inhibitor, a growth factor, collagen, an enzyme, an agent to induce directional bacterial growth, a means to impart bacteriacidal or bacteriostatic activity, an agent to destabilize metabolic activity, a vaso-dilator, an agent to inhibit or destroy biofilm formation, a light-activated agent, an ultrasound-activated agent, a sonication-activated agent, and combinations thereof.

29. A wound dressing comprising:

a first layer disposed on a first side of the dressing adapted to be applied to the wound surface, the first layer containing at least one anti-microbial agent;

a second layer adjacent to the first layer, and disposed on a side thereof opposite the first side of the dressing, the second layer containing a cell-signaling agent.

30. The wound dressing of claim 29 , wherein the first layer is an outer layer and the second layer is an inner layer, of the wound dressing.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2017
From: COVIDIEN LP
To: KPR U.S., LLC
Reel/Frame 044128/0533 →
CHANGE OF NAME Recorded May 17, 2013
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 030427/0385 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2007
From: PATEL, HARISH A.; SWANIKER, HANSEN P.; HEAGLE, DAVID G.; WARD, KATE; TRANCHEMONTAGNE, ALAIN; FINK, E. DAVID; VITARIS, RONALD F.; SHAH, CHIRAG G.; MULLIGAN, SHARON A.; DOWD, BRIAN; ORR, SCOTT
To: TYCO HEALTHCARE GROUP
Reel/Frame 019564/0860 →